NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Scope Biosciences

Scope Biosciences

Private
WageningenFrontier & Industrial Techhttps://scopebio.com/

Last Round

Seed

Jun 16, 2025

Total Funding Raised

$6.73M

Company Overview

Scope Biosciences is a biotechnology company that provides a CRISPR-Cas based molecular diagnostics platform, scopeDx®, for on-site pathogen testing in the agriculture and healthcare industries.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Biotech Equipment, Environmental Monitoring, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

CRISPR diagnosticsmolecular diagnosticspathogen detectionon-site testingpoint of need testingagri-food techAgTechfield diagnosticsnucleic acid detectiondiagnostic platformcrop pathogen testingassay developmentpoint of care testingType III CRISPRisothermal amplificationLAMPveterinary diagnosticstransplant diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scope Biosciences Comparables

Compare Scope Biosciences with similar companies based on industry and business-model similarity.

Scope Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Scope Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 16, 2025
GrantMar 7, 2024
SeedOct 23, 2023
SeedNov 5, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Jurre Steens

Founder & Chief Technology Officer

Founding Team

Niek Savelkoul

Chief Executive Officer

Executive Team

Scope Biosciences Investors

Notable investors and investment history

Scope Biosciences investors
InvestorRounds
European Innovation CouncilGrant
SHIFT InvestSeed
Oost NLSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2025

    $2.3M round with Oost NL and SHIFT Invest.

  • May 1, 2025

    Monthly visitors grew 105% MoM, reaching 336.

View all signals

Scope Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Scope Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Scope Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersWageningen
Employee Range11
Year Founded2020
Last FundingJun 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.